Pneumococcal Polysaccharide Serotype 11A
Products in Health Canada’s databases that list Pneumococcal Polysaccharide Serotype 11A as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 5
- 2 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 9
- Products in all
- 5
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| CAPVAXIVE (4 MCG)Merck Canada Inc · Status since Aug 2024 | 02549891 | Marketed | Merck Canada Inc | |
| PREVNAR 20 (2.2 MCG)Pfizer Canada Ulc · Status since Jul 2022 | 02527049 | Marketed | Pfizer Canada Ulc | |
| PNEUMO 23 (25 MCG)Sanofi Vaccines Canada Ltd. · Status since Jul 2013 | 02231259 | Cancelled Post Market | Sanofi Vaccines Canada Ltd. | |
| PNEUMOVAX 23 (25 MCG)Merck Canada Inc · Status since Dec 2021 | 00431648 | Cancelled Post Market | Merck Canada Inc | |
| PNEUMOVAX 23 (25 MCG)Merck Canada Inc · Status since Aug 2025 | 02436442 | Cancelled Post Market | Merck Canada Inc |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- CAPVAXIVESeptember 29, 2026 · NOC 38384
- PREVNAR 20March 9, 2026 · NOC 37281
- CAPVAXIVEOctober 14, 2025 · NOC 36215
- PREVNAR 20September 29, 2025 · NOC 36098
- PREVNAR 20August 30, 2024 · NOC 33908
- CAPVAXIVEJuly 15, 2024 · NOC 37230
- PREVNAR 20November 16, 2023 · NOC 32120
- PREVNAR 20July 21, 2023 · NOC 31283
- PREVNAR 20May 9, 2022 · NOC 28117